Chronic inflammation: a potential target in tauopathies
- PMID: 37059499
- DOI: 10.1016/S1474-4422(23)00116-3
Chronic inflammation: a potential target in tauopathies
Conflict of interest statement
MTH serves on the science advisory board of the Paris Brain Institute, the UK Dementia Research Institute at Imperial College London, Life and Health Sciences Research Institute of the University of Minho School of Medicine, Alector, Cyclerion, IFM Therapeutics, and T3D Therapeutics. He has received speaking honoraria from NovoNordisk, Novartis, Biogen, and Eli Lilly. CI is listed as inventor on a patent licensed by Washington University to C2N Diagnostics on the therapeutic use of anti-tau antibodies.
Comment on
-
Chronic effects of inflammation on tauopathies.Lancet Neurol. 2023 May;22(5):430-442. doi: 10.1016/S1474-4422(23)00038-8. Lancet Neurol. 2023. PMID: 37059510 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources